Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This program has been developed in collaboration with the Diversity in Life Sciences Community.
Who should attend?
- Clinical Research
- Clinical Operations
- Data transparency/data sharing
- Diversity, Equity and Inclusion
- Health Outcomes
- Medical Affairs and Communication
- Patient Advocacy
- Patient Engagement/Patient Support
- Professional Education, Training and Development
- Public Policy
- Research and Development
- Regulatory Affairs
- Strategic Planning
Learning objectives
- Recognize how to engage and be proactive to the needs of diverse communities to build trust and combat misinformation
- Identify strategies that work towards efforts of diversity, equity and inclusion with relation to the drug development lifecycle
- Restate dialogue regarding the importance of genomics in discovery science and early clinical development
- Apply how to engage Instiutional Review Boards (IRBs) and Independent Ethics Committees (IECs) on diversity, equity, and inclusion efforts within clinical trials and throughout the drug development lifecycle
- Explain the conscious decision making it takes for a company to pursue diversity in clinical trials
- Evaluate the challenges that impact diversity recruitment, enrollment, and retention in clinical trials
- Describe FDA efforts to advance the inclusion of minorities and women in clinical trials
- Identify industry efforts that support clinical trial diversity
- Explain clinical research site activities that advance clinical trial diversity through community engagement
- Discuss how to engage and support health equity and access during the post-marketing phase of the drug development lifecycle
Program Committee
-
Monique Adams, PhD, MS • Director, Clinical Innovation Lead
Janssen, United States -
Richardae Araojo, PharmD, MS • Associate Commissioner for Minority Health, Director, Office of Minority Health
FDA, United States -
Dyan Bryson, MBA • Patient Engagement Strategist/Patient Advocate
Inspired Health Strategies, United States -
Robert Fullilove, EdD • Associate Dean, Community and Minority Affairs
Columbia University, United States -
Diana Foster, BSN, PhD, MSN • CEO, Total Clinical Trial Management; Vice President, Strategy and Development
Society for Clinical Research Sites, United States -
Mustafa Syed • Treasurer, DIA Student Chapter
St. Johns University, United States -
Amy Sitnick, MA • Vice President, Marketing
Greenphire, United States -
Charlotte Jones-Burton, MD, MS • Vice President
Otsuka Pharmaceutical, United States -
Adaeze Enekwechi, PhD • Board Member
Alliance for Health Policy, United States